Suggested Topics within your search.
Suggested Topics within your search.
- Anesthesia 19
- History 19
- Management 10
- Research 10
- English language 9
- Psychology 9
- Constitutional court 8
- History and criticism 8
- Law 8
- biology 8
- geography 8
- Court of Appeal 7
- Judgements and orders 7
- kiswahili 7
- Business 6
- Gynecology 6
- Health 6
- agriculture 6
- research 6
- Economics 5
- Judgement and orders 5
- Law reports, digests, etc 5
- Methodology 5
- Obstetrics 5
- Psychological tests 5
- Report writing 5
- Rhetoric 5
- Study and teaching 5
- engineering 5
- methods 5
-
289641
Utilisation of alcohol-related treatment after a first alcohol use disorder diagnosis in Hamburg, Germany
Published 2025-01-01Get full text
Article -
289642
Uluslararası Güvenliği Sağlama Açısından Bir Yol Haritası: Sambi-Mandara Güvenlik Eylem Planı Örneği
Published 2024-04-01Get full text
Article -
289643
-
289644
-
289645
-
289646
-
289647
-
289648
Quantitative proteomic analysis unveils a critical role of VARS1 in hepatocellular carcinoma aggressiveness through the modulation of MAGI1 expression
Published 2025-01-01“…VARS1-overexpressing Hep3B cells were used for in vivo studies [Extreme Limiting Dilution Assay (ELDA) and orthotopic tumour formation]. …”
Get full text
Article -
289649
Light intensity-dependent arrestin switching for inactivation of a light-sensitive GPCR, bistable opsin
Published 2025-02-01Get full text
Article -
289650
Genetic interaction between oxidative stress and body mass index in a Spanish population
Published 2025-03-01Get full text
Article -
289651
-
289652
-
289653
-
289654
-
289655
-
289656
Microenvironment Influences on Human Umbilical Cord Mesenchymal Stem Cell-Based Bone Regeneration
Published 2021-01-01Get full text
Article -
289657
Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia
Published 2025-01-01Get full text
Article -
289658
-
289659
-
289660
Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study
Published 2014-07-01“…Total of 153 patients have completed 12-week course of triple therapy and 4-week course of peginterferon-alpha and ribavirin treatment (48% cirrhotic patients, 97% – HCV-1b). The level of HCV RNA was undetectable both at the 4-th week, and at the 12-th week (extended rapid virologic response) in 42 (75%) of 56 previously untreated patients, in 34 (89%) of 38 with relapses after previous treatment, in 4 (57%) of 7 with previous incomplete response, in 22 (52%) of 42 with the previous zero response and in 7 (70%) of 10 with previous virologic breakthrough. …”
Get full text
Article